A tablet of clopidogrel remaining in the lower esophagus after primary percutaneous coronary intervention for acute myocardial infarction.
Department of Cardiovascular Medicine, Saitama International Medical Center, Saitama Medical University, Hidaka, Japan.
Tomomi
T
Koizumi
Department of Cardiovascular Medicine, Saitama International Medical Center, Saitama Medical University, Hidaka, Japan.
Shigeyuki
S
Nishimura
D000368:Aged; D000077144:Clopidogrel; D003131:Combined Modality Therapy; D004947:Esophagus / Q000187:drug effects* / Q000473:pathology; D005260:Female; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy*; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D013607:Tablets; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D013607:Tablets; D000077144:Clopidogrel; D013988:Ticlopidine